1. Home
  2. Programs
  3. Practical Dermatology
advertisement

ADORING Trials Show Broad Efficacy, Early Itch Relief

Silverberg
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
  • Overview

    Jonathan Silverberg, MD, discusses findings from the ADORING trials, the potential breadth of tapinarof's mechanism of action, and why early itch improvement matters in topical atopic dermatitis treatment. 

Recommended
Details
Presenters
  • Overview

    Jonathan Silverberg, MD, discusses findings from the ADORING trials, the potential breadth of tapinarof's mechanism of action, and why early itch improvement matters in topical atopic dermatitis treatment. 

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free